Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.
about
Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus.Differential expression of Vibrio vulnificus capsular polysaccharideMonoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro modelsThe pyrH gene of Vibrio vulnificus is an essential in vivo survival factor.
P2860
Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Preclinical immunoprophylactic ...... vaccines of Vibrio vulnificus.
@ast
Preclinical immunoprophylactic ...... vaccines of Vibrio vulnificus.
@en
type
label
Preclinical immunoprophylactic ...... vaccines of Vibrio vulnificus.
@ast
Preclinical immunoprophylactic ...... vaccines of Vibrio vulnificus.
@en
prefLabel
Preclinical immunoprophylactic ...... vaccines of Vibrio vulnificus.
@ast
Preclinical immunoprophylactic ...... vaccines of Vibrio vulnificus.
@en
P2093
P2860
P1476
Preclinical immunoprophylactic ...... vaccines of Vibrio vulnificus.
@en
P2093
P2860
P304
P407
P577
1996-06-01T00:00:00Z